Search details
1.
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective study.
J Viral Hepat
; 29(1): 26-34, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34582610
2.
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study.
Liver Int
; 42(7): 1618-1628, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-38009600
3.
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study.
Ann Hepatol
; 27(3): 100683, 2022.
Article
in English
| MEDLINE | ID: mdl-35151902
4.
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.
J Transl Med
; 17(1): 292, 2019 08 28.
Article
in English
| MEDLINE | ID: mdl-31462268
5.
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.
Dig Dis Sci
; 64(10): 3013-3019, 2019 10.
Article
in English
| MEDLINE | ID: mdl-30937719
6.
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.
Infection
; 46(2): 231-238, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29335905
7.
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
J Gastroenterol Hepatol
; 33(5): 1123-1130, 2018 May.
Article
in English
| MEDLINE | ID: mdl-28994145
8.
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes.
Transpl Int
; 30(12): 1253-1265, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28799277
9.
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma.
Eur J Gastroenterol Hepatol
; 35(7): 734-741, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-37115974
10.
Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation.
Clin Gastroenterol Hepatol
; 15(11): 1800-1802, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28552801
11.
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients.
ScientificWorldJournal
; 2012: 564706, 2012.
Article
in English
| MEDLINE | ID: mdl-22654628
12.
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study.
Eur J Intern Med
; 79: 70-75, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32616342
13.
Toward Zero Hepatitis C Virus-Related Mortality as a Prerequisite for the Release of Resources in a Center for Follow-up of Liver Transplant.
Transplant Proc
; 51(9): 2958-2961, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31629537
14.
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program.
Sci Rep
; 9(1): 585, 2019 01 24.
Article
in English
| MEDLINE | ID: mdl-30679515
15.
Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
Antivir Ther
; 13(2): 307-18, 2008.
Article
in English
| MEDLINE | ID: mdl-18505182
16.
Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study.
J Med Virol
; 80(9): 1547-53, 2008 Sep.
Article
in English
| MEDLINE | ID: mdl-18649338
17.
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort.
Minerva Gastroenterol Dietol
; 64(1): 1-9, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29307146
18.
Serial Liver Stiffness Measurements and Monitoring of Liver-Transplanted Patients in a Real-Life Clinical Practice.
Hepat Mon
; 16(12): e41162, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-28123442
19.
Triple (interferon, ribavirin, amantadine) versus double (interferon, ribavirin) re-therapy for interferon relapser genotype 1b HCV chronic active hepatitis patients.
Hepatol Res
; 25(4): 355-363, 2003 Apr.
Article
in English
| MEDLINE | ID: mdl-12699845
20.
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.
Cancer Chemother Pharmacol
; 66(5): 837-44, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20041325